Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR27 | Q9NS67 | 2/20 | 0.46 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | CCR2 | P41597 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | PRSS12 | P56730 | 1/20 | 0.39 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834401 | 0.93 | GPR27 (0.46) | GPR27AVPR2ALBALDH1A1MCL1 | |
| SCHEMBL6834095 | 0.92 | GPR27 (0.46) | GPR27AVPR2ALBALDH1A1HSPD1 | |
| SCHEMBL6833969 | 0.91 | GPR27 (0.48) | GPR27AVPR2ALBMCL1HSPD1 | |
| SCHEMBL6834064 | 0.88 | ALB (0.42) | ALBMCL1HIF1A | |
| SCHEMBL6833770 | 0.88 | PTPN2 (0.40) | ALBMCL1PTPN2PTPN1PTPN5 | |
| SCHEMBL6833074 | 0.87 | ALB (0.41) | ALBMCL1HIF1A | |
| SCHEMBL6814368 | 0.86 | GPR27 (0.46) | GPR27AVPR2ALBALDH1A1MCL1 | |
| SCHEMBL6834155 | 0.85 | F2 (0.50) | ALBMEN1KMT2AHIF1A | |
| SCHEMBL6818576 | 0.85 | GPR27 (0.46) | GPR27AVPR2ALBALDH1A1HSPD1 | |
| SCHEMBL6707931 | 0.84 | GPR27 (0.41) | GPR27AVPR2ALDH1A1HSPD1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | GPR27 1964/4885AVPR2 4057/4885ALB 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.